Searchable abstracts of presentations at key conferences in endocrinology

ea0064011 | Effect of exogenous testosterone administration on serum oestradiol levels in assigned female at birth transgender people: result from a large transgender cohort | BES2019

Effect of exogenous testosterone administration on serum oestradiol levels in assigned female at birth transgender people: result from a large transgender cohort.

Defreyne J , Aers XP , Collet S , Wiepjes CM , Fisher AD , Schreiner T , Den Heijer M , Kaufman JM , T'Sjoen G

Aim: The changes in serum oestradiol levels in assigned female at birth (AFAB) transgender people receiving testosterone therapy have not been elucidated. How serum oestradiol levels change after initiation of testosterone therapy, if these levels should be monitored and whether altered oestradiol levels will result in adverse health outcomes, remains unclear.Methods: This prospective cohort study was part of the European Network for the Investigation of...

ea0071010 | Vaginal bleeding and spotting in transgender men after initiation of testosterone therapy: A prospective cohort study (ENIGI) | BES2020

Vaginal bleeding and spotting in transgender men after initiation of testosterone therapy: A prospective cohort study (ENIGI)

J Defreyne , Y Vanwonterghem , S Collet , S Iwamoto , CM Wiepjes , AD Fisher , T Schreiner , M Den Heijer , G T'Sjoen

Background: Previous cross-sectional studies have described amenorrhea in cohorts of transgender men on intramuscular or subcutaneous testosterone injections. It remains uncertain which testosterone preparations most effectively suppress vaginal bleeding and when amenorrhea occurs after testosterone initiation.Aim: To investigate the clinical effects of various testosterone preparations on vaginal bleeding and spotting in transgender men.<p class="ab...